| Friday, 19 June 2020 | ||
| 08:50-09:00 | Welcome and introduction | E. Mayer |
| 09:00-09:20 | Developing concept and definition of CTEPH | G. Simonneau |
| Plenary 1: Pathophysiology, epidemiology (Chairs: M. Delcroix and G. Simonneau) | ||
| 09:20-09:40 | Early diagnosis of CTEPH after acute PE: state of the art 2020 | E. Klok |
| 09:40-10:00 | What have we learned from GWAS? | M. Toshner |
| 10:00-10:20 | The role of the bronchial circulation and microvasculopathy | E. Fadel |
| 10:20-10:50 | Coffee break and poster viewing | |
| Plenary 2: Diagnosis and imaging (Chairs: J. Pepke-Zaba and E. Fadel) | ||
| 10:50-11:10 | Mechanisms of cardiac dysfunction in CTEPH | A. Vonk Noordegraaf |
| 11:10-11:40 | Beyond V/Q scan: cutting edge imaging modalities | N. Screaton |
| 11:40-12:10 | How can imaging help select treatment modalities? | E. Mayer |
| 12:10-13:40 | Lunch break and poster viewing | |
| Plenary 3: Pulmonary endarterectomy (Chairs: M. Madani and N. Kim) | ||
| 13:40-14:10 | Simulation-based CTEPH training | O. Mercier |
| 14:10-14:40 | Peri-operative and complication management | D. Jenkins |
| 14:40-15:10 | Distal endarterectomy | M. Madani |
| 15:10-15:40 | Coffee break and poster viewing | |
| Plenary 4: Balloon pulmonary angioplasty (Chairs: H. Matsubara and I. Lang) | ||
| 15:40-16:10 | BPA learning curve: the French experience | P. Brenot |
| 16:10-16:50 | State of the art techniques and complication management | H. Matsubara |
| 16:50-17:05 | International BPA registry | N. Kim |
| Abstract presentations (Chair: M. Delcroix) | ||
| 17:05-17:50 | Presentation of 4 abstracts selected by abstract review committee | |
| 19:00-22:30 | Conference dinner | |
| Saturday, 20 June 2020 | ||
| Case presentations: Meet the expert | ||
| 08:30-09:15 | Medical therapy | M. Delcroix, G. Simonneau, J. Pepke-Zaba |
| BPA | H. Matsubara, I. Lang, N. Kim | |
| PEA | E. Mayer, E. Fadel, M. Madani, D. Jenkins | |
| Plenary 5: Medical therapy (Chairs: N. Kim and M. Delcroix) | ||
| 09:20-09:50 | Role of medical therapy in CTEPH | A. Ghofrani |
| 09:50-10:20 | Upfront combination therapy in CTEPH | M. Humbert |
| 10:20-10:50 | Medical therapy before and after BPA? | I. Lang |
| 10:50-11:20 | Coffee break and poster viewing | |
| Plenary 6: Combination of treatment modalities (Chairs: D. Jenkins and E. Mayer) | ||
| 11:20-11:40 | Medical vs BPA (RACE) | X. Jaïs |
| 11:40-12:00 | Multimodal interventions | C. Wiedenroth |
| Plenary 7: Hot topics (Chairs: M. Madani and I. Lang) | ||
| 12:00-12:20 | Anticoagulant options in CTEPH | M. Hoeper |
| 12:20-12:40 | CTED: exercise haemodynamics and treatment evidence | S. Guth |
| 12:40-13:00 | Update on CTEPH registries | M. Delcroix |
| 13:00-13:15 | Closing remarks | N. Kim |
Endorsement
ICC 2020 will be endorsed by
